Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors

被引:29
|
作者
Bokaei, Payman Baradar
Ma, Xue-Zhong
Byczynski, Bartosz
Keller, Jeremy
Sakac, Darinka
Fahim, Soad
Branch, Donald R.
机构
[1] Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada
[3] Canadian Red Cross Blood Transfus Serv, Toronto, ON M5G 2M1, Canada
[4] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
关键词
vasoactive intestinal peptide receptors; splice variants; five-transmembrane; VIPR1; VPAC1; VIPR2; VPAC2; GPCR;
D O I
10.1016/j.ygeno.2006.07.008
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The seven- transmembrane (7TM) G-protein-coupled neuroendocrine receptors VPAC1 (HGNC approved gene symbol VIPR1) and VPAC2 (HGNC approved gene symbol VIPR2) are expressed in different tissues and involved in the regulation of important biological functions. We now report the identification and characterization of novel five-transmembrane(5TM) forms of both human VPAC1 and human VPAC2. These alternatively spliced variant mRNAs result from the skipping of exons 10/11, spanning the third intracellular loop, the fourth extracellular loop, and the transmembrane regions 6 and 7, producing in-frarne 5TM receptors predicted to lack a G-protein-binding motif. RT-PCR showed that these 5TM receptors are differentially expressed in transformed and normal cells. Translation of the 5TM protein was demonstrated by transfection and expression in CHO cells. Following agonist stimulation, differential signaling of the 7TM versus 5TM forms was shown both for the activation of adenylate cyclase and for tyrosine phosphorylation. The identification of these splice variants in various cells and their expression and differential signal transduction compared to the 7TM form suggest that these novel receptors have biological relevance. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:791 / 800
页数:10
相关论文
共 50 条
  • [31] Comparative distribution of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide immunoreactivity in the chicken forebrain
    Peeters, K
    Berghman, LR
    Vandesande, F
    TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY: FROM MOLECULAR TO INTEGRATIVE BIOLOGY, 1998, 839 : 417 - 419
  • [32] Pituitary adenylate cyclase-activating polypeptide
    Gonzalez, BJ
    Basille, M
    Vaudry, D
    Fournier, A
    Vaudry, H
    ANNALES D ENDOCRINOLOGIE, 1998, 59 (05) : 364 - 405
  • [33] Pituitary adenylate cyclase-activating polypeptide
    Li, XL
    Zhao, XX
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2001, 28 (02) : 140 - 144
  • [34] Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors:: distribution and involvement in the secretion of Podarcis sicula adrenal gland
    Valiante, Salvatore
    Prisco, Marina
    Sciarrillol, Rosaria
    De Falco, Maria
    Capaldo, Anna
    Gay, Flarninia
    Andreuccetti, Piero
    Laforgia, Vincenza
    Varano, Lorenzo
    JOURNAL OF ENDOCRINOLOGY, 2008, 196 (02) : 291 - 303
  • [35] Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin
    Reubi, JC
    Läderach, U
    Waser, B
    Gebbers, JO
    Robberecht, P
    Laissue, JA
    CANCER RESEARCH, 2000, 60 (11) : 3105 - 3112
  • [36] DISTRIBUTION OF VASOACTIVE INTESTINAL PEPTIDE, PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE, NITRIC OXIDE SYNTHASE, AND THEIR RECEPTORS IN HUMAN AND RAT SPHENOPALATINE GANGLION
    Csati, A.
    Tajti, J.
    Kuris, A.
    Tuka, B.
    Edvinsson, L.
    Warfvinge, K.
    NEUROSCIENCE, 2012, 202 : 158 - 168
  • [37] Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians
    Yon, L
    Alexandre, D
    Montéro, M
    Chartrel, N
    Jeandel, L
    Vallarino, M
    Conlon, JM
    Kikuyama, S
    Fournier, A
    Gracia-Navarro, F
    Roubos, E
    Chow, B
    Arimura, A
    Anouar, Y
    Vaudry, H
    MICROSCOPY RESEARCH AND TECHNIQUE, 2001, 54 (03) : 137 - 157
  • [38] Effects of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide, and somatostatin on the release of thyrotropin from the bullfrog pituitary
    Okada, Reiko
    Yamamoto, Kazutoshi
    Ito, Yoichi
    Chartrel, Nicolas
    Leprince, Jerome
    Fournier, Alain
    Vaudry, Hubert
    Kikuyama, Sakae
    VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY, 2006, 1070 : 474 - 480
  • [39] Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development
    Basille, M
    Cartier, D
    Vaudry, D
    Lihrmann, I
    Fournier, A
    Freger, P
    Gallo-Payet, N
    Vaudry, H
    Gonzalez, B
    JOURNAL OF COMPARATIVE NEUROLOGY, 2006, 496 (04) : 468 - 478
  • [40] Pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland
    Yon, L
    Breault, L
    Contesse, V
    Bellancourt, G
    Delarue, C
    Fournier, A
    Lehoux, JG
    Gallo-Payet, N
    Vaudry, H
    VIP, PACAP, AND RELATED PEPTIDES: THIRD INTERNATIONAL SYMPOSIUM, 1998, 865 : 416 - 419